133 related articles for article (PubMed ID: 18066130)
1. Effect of Ginkgo biloba extract on oxidative metabolism of valproic acid in hepatic microsomes from donors with the CYP2C9*1/*1 genotype.
Numa AM; Abbott FS; Chang TK
Can J Physiol Pharmacol; 2007 Sep; 85(9):848-55. PubMed ID: 18066130
[TBL] [Abstract][Full Text] [Related]
2. Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.
Kiang TK; Ho PC; Anari MR; Tong V; Abbott FS; Chang TK
Toxicol Sci; 2006 Dec; 94(2):261-71. PubMed ID: 16945988
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
Lau AJ; Chang TK
Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
[TBL] [Abstract][Full Text] [Related]
4. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
5. Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid.
Sadeque AJ; Fisher MB; Korzekwa KR; Gonzalez FJ; Rettie AE
J Pharmacol Exp Ther; 1997 Nov; 283(2):698-703. PubMed ID: 9353388
[TBL] [Abstract][Full Text] [Related]
6. Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomes.
Ho PC; Abbott FS; Zanger UM; Chang TK
Pharmacogenomics J; 2003; 3(6):335-42. PubMed ID: 14597963
[TBL] [Abstract][Full Text] [Related]
7. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
Kuo If; Chen J; Chang TK
Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
[TBL] [Abstract][Full Text] [Related]
8. The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.
Tan L; Yu JT; Sun YP; Ou JR; Song JH; Yu Y
Clin Neurol Neurosurg; 2010 May; 112(4):320-3. PubMed ID: 20089352
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Ginkgo biloba extract as an activator of human glucocorticoid receptor.
Lau AJ; Yang G; Rajaraman G; Baucom CC; Chang TK
J Ethnopharmacol; 2013 Jan; 145(2):670-5. PubMed ID: 23220176
[TBL] [Abstract][Full Text] [Related]
10. Influence of CYP2C9 polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian patients.
Amini-Shirazi N; Ghahremani MH; Ahmadkhaniha R; Mandegary A; Dadgar A; Abdollahi M; Shadnia S; Pakdaman H; Kebriaeezadeh A
Toxicol Mech Methods; 2010 Oct; 20(8):452-7. PubMed ID: 20602621
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human cytochromes P450 by components of Ginkgo biloba.
von Moltke LL; Weemhoff JL; Bedir E; Khan IA; Harmatz JS; Goldman P; Greenblatt DJ
J Pharm Pharmacol; 2004 Aug; 56(8):1039-44. PubMed ID: 15285849
[TBL] [Abstract][Full Text] [Related]
12. Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo.
Mohutsky MA; Anderson GD; Miller JW; Elmer GW
Am J Ther; 2006; 13(1):24-31. PubMed ID: 16428919
[TBL] [Abstract][Full Text] [Related]
13. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
Chang TK; Chen J; Teng XW
Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
Mohamed MF; Frye RF
Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
[TBL] [Abstract][Full Text] [Related]
15. Modulation of CYP1B1 and CYP1A1 gene expression and activation of aryl hydrocarbon receptor by Ginkgo biloba extract in MCF-10A human mammary epithelial cells.
Rajaraman G; Yang G; Chen J; Chang TK
Can J Physiol Pharmacol; 2009 Sep; 87(9):674-83. PubMed ID: 19794518
[TBL] [Abstract][Full Text] [Related]
16. Ginkgolide A contributes to the potentiation of acetaminophen toxicity by Ginkgo biloba extract in primary cultures of rat hepatocytes.
Rajaraman G; Chen J; Chang TK
Toxicol Appl Pharmacol; 2006 Dec; 217(2):225-33. PubMed ID: 17045319
[TBL] [Abstract][Full Text] [Related]
17. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
[TBL] [Abstract][Full Text] [Related]
18. P450-catalyzed in-chain desaturation of valproic acid: isoform selectivity and mechanism of formation of Delta 3-valproic acid generated by baculovirus-expressed CYP3A1.
Fisher MB; Thompson SJ; Ribeiro V; Lechner MC; Rettie AE
Arch Biochem Biophys; 1998 Aug; 356(1):63-70. PubMed ID: 9681992
[TBL] [Abstract][Full Text] [Related]
19. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals.
van Beek TA; Montoro P
J Chromatogr A; 2009 Mar; 1216(11):2002-32. PubMed ID: 19195661
[TBL] [Abstract][Full Text] [Related]
20. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL
Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
